<?xml version="1.0" encoding="UTF-8"?><CAS version="2"><uima.cas.Sofa _indexed="0" _id="1" sofaNum="1" sofaID="_InitialView" mimeType="text" sofaString="P09581834A2578 Taken together, these results suggest that silymarin may exert a strong anticarcinogenic effect against PCA and that this effect is likely to involve impairment of erbB1-SHC-mediated signaling pathway, induction of CDKIs, and a resultant G1 arrest."/><uima.tcas.DocumentAnnotation _indexed="1" _id="8" _ref_sofa="1" begin="0" end="263" language="x-unspecified"/><edu.cmu.tanl.type.gene _indexed="1" _id="13" _ref_sofa="1" begin="139" end="143" Gene="erbB1"/><edu.cmu.tanl.type.gene _indexed="1" _id="18" _ref_sofa="1" begin="145" end="147" Gene="SHC"/><edu.cmu.tanl.type.gene _indexed="1" _id="23" _ref_sofa="1" begin="185" end="189" Gene="CDKIs"/></CAS>